Skip to main content

Day: May 26, 2023

Interoil executes Purchase and Sale Agreement for the acquisition of an additional participation in Santa Cruz concessions. Successful application for new Gas Sales Contract in Santa Cruz

Oslo, 26 May 2023 Santa Cruz Acquisition Interoil Exploration and Production ASA (the “Company” or “IOX“) is pleased to announce the execution of a Purchase and Sale Agreement (the “PSA“) whereby Interoil and the Argentine company Selva María Oil S.A. (“SMO”, and with Interoil each a “Buyer” and together the “Buyers”) have agreed to acquire from Echo Energy Plc (“Echo”) and its subsidiaries Eco Energy CDL OP Ltd. and Eco Energy TA OP Ltd. (both such subsidiaries together with Echo, the “Sellers”) (i) 65% of the aggregate interest and assets in and to five exploitation concessions located in the Province of Santa Cruz, Argentina, namely CA-1 “Campo Bremen”, CA-4 “Moy Aike”, CA-6 “Chorrillos”, CA-10 “Palermo Aike” and CA-9 “Océano” (the “Exploitation Concessions’), and the related joint venture (the “UTE”,...

Continue reading

Michelin : Michelin sells its activities in Russia to Power International Tires LLC

  Clermont-Ferrand, May 26, 2023 Michelin is selling its activities in Russiato Power International Tires LLC After suspending its industrial activities in Russia on March 15, 2022, following the start of the conflict in the Ukraine, Michelin is today announcing the signature of an agreement with Power International Tires LLC for the purchase of its two local companies, Michelin Russia Tyre Manufacturing Company (MRTMC) LLC and Camso CIS LLC. A known partner of Michelin, Power International Tires is one of the main tire distributors in Russia and has a presence throughout the country.Approved by the competent local authorities, this agreement will allow for saving 250 jobs, mainly based in Davydovo. The option to pass the activity on to local management was not possible due to major difficulties preventing these activities from being rendered...

Continue reading

DMG Announces Release Date for Second Quarter 2023 Results, Energy Web’s Certification for Sustainable Bitcoin Mining

VANCOUVER, British Columbia, May 26, 2023 (GLOBE NEWSWIRE) — DMG Blockchain Solutions Inc. (TSX-V: DMGI) (OTCQB US: DMGGF) (FRANKFURT: 6AX) (“DMG” or the “Company”), a vertically integrated blockchain and cryptocurrency technology company, today announces it will release financial results for its second quarter 2023 ending March 31, 2023 on Tuesday, May 30 after the market close. The Company will host a conference call to review its results and provide a corporate update on May 31, 2023 at 4:15 pm ET. DMG Receives Energy Web’s Certification for Sustainable Bitcoin Mining DMG announces it is among the first five miners to be certified for sustainable Bitcoin mining by Energy Web, which is an independent non-profit that develops open-source software for clean energy solutions. On May 24, Energy Web announced its launch of Green Proofs...

Continue reading

Novo Nordisk A/S: Once-weekly Sogroya® (somapacitan) receives CHMP positive opinion for expanded use in children and adolescents with growth hormone deficiency

Bagsværd, Denmark, 26 May 2023 – Novo Nordisk today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recommending once-weekly Sogroya® (somapacitan) for replacement of endogenous growth hormone (GH) in children aged three years and above, and adolescents with growth failure due to growth hormone deficiency. Symptoms of growth hormone deficiency in children often start early in life, leading to short stature as well as other growth-related health problems.1 Current treatment for growth hormone deficiency typically requires daily injections of growth hormone.2 However, frequent injections can be burdensome, disrupting daily life, reducing adherence and thereby affecting clinical outcomes – particularly in children.3 “Today’s positive CHMP opinion is...

Continue reading

EXEL Industries: first half 2022-2023 results

 First half 2022–2023 results Return to profit levels in line with expectations H1 results(October 2022–March 2023) 2021–2022(€m) 2022–2023(€m)SALES406.9 483.1RECURRING EBITDA117.4 29.0% of sales4.3% 6.0%CURRENT OPERATING INCOME (EBIT)7.2 15.8% of sales 1.8% 3.3%Non‐recurring items (1.9) 0.1Net financial income/(expense) 0.3 (8.3)Tax and share of profit of associates (3.6) (3.4)NET INCOME 1.9 4.2% of sales 0.5% 0.9%NET FINANCIAL DEBT (154.6) (176.4) Sales6 months(October 2022–March 2023)2021–2022 2022–2023 Change (reported) Change (LFL2)Reported Reported €m % €m %                AGRICULTURAL SPRAYING 186.8 236.8 +50.0 +26.7% +44.5 +23.8%SUGAR BEET HARVESTERS39.2 53.8 +14.6 +37.4% +15.3 +39.0%LEISURE55.2 62.1 +6.9 +12.5% +2.5 +4.5%INDUSTRY125.7 130.4 +4.7 +3.7% +3.1 +2.5%             EXEL...

Continue reading

JLT Mobile Computers makes strategic acquisition – becomes a shareholder in its Australian sales partner

JLT has acquired 33% of the shares in Control Synergy, JLT’s distributor in Australia for the past twenty years, thereby creating new expansion opportunities in the Australian market. Växjö, Sweden, 26 May 2023 * * * JLT Mobile Computers, a leading supplier of rugged computers for demanding environments, has acquired 33% of the shares in its Australian sales partner, Control Synergy, with the option to acquire the remaining shares in the company in five years. Key highlights of the acquisitionCreates expansion opportunities in Australia, and long term also in the rest of the APAC region Raises the service level in the Australian market Increases knowledge exchange to drive growth Enhances possibilities for customer-centric product and service developmentNew expansion opportunities and raised service level Over the past 20 years,...

Continue reading

Vivoryon Therapeutics Successfully Completes Private Placement Raising EUR 25 Million

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN, AUSTRALIA, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE OR FORM AN OFFER FOR SALE OF, OR THE SOLICITATION OF AN OFFER TO BUY, THE SECURITIES REFERRED TO HEREIN IN ANY JURISDICTION, INCLUDING THE UNITED STATES, CANADA, AUSTRALIA, SOUTH AFRICA, JAPAN OR ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES WOULD BE PROHIBITED BY APPLICABLE LAW.Vivoryon Therapeutics Successfully Completes Private Placement Raising EUR 25 MillionTo access the press release, please click here.

Continue reading

Roche to present new data in blood cancers and solid tumours from its broad portfolio at ASCO 2023

Basel, 26 May 2023 – Roche (SIX: RO, ROG; OTCQX: RHHBY) will be presenting new data on six approved and investigational medicines across ten cancer types at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, held 2 – 6 June.  Highlights include new data spanning treatments for lymphoma and hepatocellular carcinoma (HCC): Developing new treatment options for people with blood cancersExtended follow-up data for Columvi® (glofitamab) of almost two years (20 months) from the pivotal phase II NP30179 study, further investigating the potential of fixed-duration Columvi to provide durable responses in people with relapsed or refractory (R/R) large B-cell lymphoma (LBCL) Early data from the phase Ib NP40126 study of Columvi in combination with Polivy plus rituximab, cyclophosphamide, doxorubicin and prednisone (R-CHP)...

Continue reading

Nyrstar NV releases notice for the 2022 annual general shareholders’ meeting to be held on 27 June 2023

Regulated Information Nyrstar NV releases notice for the 2022 annual general shareholders’ meeting to be held on 27 June 2023 26 May 2023 at 07.00 CEST Nyrstar NV (the “Company”) today issued the notice for the 2022 annual general shareholders’ meeting to be held on 27 June 2023 at 10:00 a.m. CEST. The annual general meeting will be held physically with no virtual option available. The practical modalities of the meeting are set out in the notice to the meeting which has been published on the Company’s website (https://www.nyrstar.be/en/investors/share-and-bondholder-information/shareholder-meetings). The full notice, including agenda, proposed resolutions and explanatory note can be found on the aforementioned Nyrstar NV website. About Nyrstar NV The Company is incorporated in Belgium and is listed on Euronext Brussels under the...

Continue reading

Cnova N.V.: Opening of conciliation proceedings at Cdiscount

   CNOVA N.V. – Opening of conciliation proceedings at Cdiscount Amsterdam – May 26, 2023, 7:00 CET – Cnova N.V. (Euronext Paris: CNV; ISIN: NL0010949392) (“Cnova” or the “Company”) and its Board of Directors announce the opening of conciliation proceedings at Cdiscount level. On May 23, 2023, the French Company’s subsidiaries: Cdiscount, Maas, C-Shield, C-Technology, C-Logistics, Carya and CLR, requested from the President of the Paris Commercial Court the opening of conciliation proceedings to their benefit, under the aegis of SELARL BCM (Me Eric Bauland) and of SCP BTSG² (Me Marc Sénéchal), for an initial period of four months, possibly extendable for one additional month. These conciliation proceedings are part of the more global context of the conciliation proceedings opened to the benefit of Groupe Casino, for the purpose of engaging...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.